New test will probe genetics to predict reaction to chemotherapy and tailor treatment
Cancer patients in England will be offered a new test which aims to tailor treatments to their genetics and avoid toxic side-effects.
People with some cancers will receive a blood test which detects whether they are genetically prone to experiencing the more serious effects of chemotherapy drugs.
